The NATO Innovation Fund has made its first investment in biotechnology, co-funding $35 million for Portal Biotech, a British company specializing in biothreat detection through protein sequencing. This technology, backed by artificial intelligence, is essential for biosecurity, enabling continuous monitoring of pathogens in diverse environments. The fund, created in 2022, aims to invest more than $1 billion in technologies to strengthen NATO's defenses.
Sources
NATO se implică financiar într-o companie de biotehnologie, pentru a contacara amenințările biologice - Economica.net
Premieră - NATO se implică financiar într-o companie de biotehnologie
Premieră - NATO se implică financiar într-o companie de biotehnologie
NATO se implică financiar într-o companie de biotehnologie pentru a contracara amenințările biologice
NATO se implică financiar într-o companie de biotehnologie pentru a contracara ameninţările biologice
Latest News
11:04
Alexandru Rogobete proposes expanding genetic testing to six types of cancer, with reimbursement expected from January 1, 2027
11:04
President of Mongolia, Ukhnaa Khürelsükh, resigned following corruption allegations and the threat of impeachment
11:00
Brad Pitt announces that filming for “Ocean’s 14” could begin toward the end of next year
10:49
Florin Manole supports indexing pensions by 7.3% in 2027 despite budget constraints
10:46
Protest at Nikolaus Lenau High School in Timișoara: Students refuse to attend classes after a knife incident
See more news